scholarly journals Hyperhomocysteinemia and Increased Risk of Retinopathy: A cross-sectional, case-control study in patients with type 2 diabetes

Diabetes Care ◽  
2002 ◽  
Vol 25 (12) ◽  
pp. 2361-2361 ◽  
Author(s):  
A. Parvanova ◽  
I. Iliev ◽  
B. D. Dimitrov ◽  
F. Arnoldi ◽  
J. Zaletel ◽  
...  
2019 ◽  
Vol 2019 ◽  
pp. 1-7
Author(s):  
Jian Zhu ◽  
Lu Yuan ◽  
Wen-ji Ni ◽  
Yong Luo ◽  
Jian-hua Ma

Insulin antibody (IA) may potentially affect a patient’s glycemic control due to its variability in both binding and/or releasing insulin. However, the association between IA titer and daily glycemic variability (GV) is still unknown. We thus performed this cross-sectional, retrospective case-control study to assess the relationship between IA titer and mean amplitude glycemic excursion (MAGE) in type 2 diabetes mellitus (T2DM) patients using a continuous glucose monitoring (CGM) system. We recruited 100 eligible patients (IA>5%, IA positive) and divided them into two groups—a low (L) group and a high (H) group—based on their IA titer. The control (C) group consisted of 47 patients (IA≤5%, IA negative) matched for age, BMI, gender, and glycosylated hemoglobin A1c (HbA1c). The CGM determined the GV of enrolled patients. The primary outcome was the relationship between the IA titer and the MAGE, and the secondary outcome was the differences of GV among the three groups. We found that patients in the H group had higher levels of blood glucose fluctuation parameters than those in the L and C groups. The Ln(IA) was positively correlated with Ln(MAGE) even after adjusting for age, gender, BMI, HbA1c, and fasting and postprandial C-peptide(r=0.423, p<0.001). Multiple linear stepwise regression analysis revealed that Ln(IA) was an independent factor of Ln(MAGE) (beta=0.405, p<0.001). In conclusion, the higher circulating IA titer was associated with increased MAGE in T2DM patients, indicating that those patients with elevated IA titer should receive GV assessment and individualized treatment.


2010 ◽  
Vol 163 (3) ◽  
pp. 427-434 ◽  
Author(s):  
José Miguel Dora ◽  
Walter Escouto Machado ◽  
Jakeline Rheinheimer ◽  
Daisy Crispim ◽  
Ana Luiza Maia

ObjectiveThe type 2 deiodinase (D2) is a key enzyme for intracellular triiodothyronine (T3) generation. A single-nucleotide polymorphism in D2 (Thr92Ala) has been associated with increased insulin resistance in nondiabetic and type 2 diabetes (DM2) subjects. Our aim was to evaluate whether the D2 Thr92Ala polymorphism is associated with increased risk for DM2.Design and methodsA case–control study with 1057 DM2 and 516 nondiabetic subjects was performed. All participants underwent genotyping of the D2 Thr92Ala polymorphism. Additionally, systematic review and meta-analysis of the literature for genetic association studies of D2 Thr92Ala polymorphism and DM2 were performed in Medline, Embase, LiLacs, and SciELO, and major meeting databases using the terms ‘rs225014’ odds ratio (OR) ‘thr92ala’ OR ‘T92A’ OR ‘dio2 a/g’.ResultsIn the case–control study, the frequencies of D2 Ala92Ala homozygous were 16.4% (n=173) versus 12.0% (n=62) in DM2 versus controls respectively resulting in an adjusted OR of 1.41 (95% confidence intervals (CI) 1.03–1.94, P=0.03). The literature search identified three studies that analyzed the association of the D2 Thr92Ala polymorphism with DM2, with the following effect estimates: Mentuccia (OR 1.40 (95% CI 0.78–2.51)), Grarup (OR 1.09 (95% CI 0.92–1.29)), and Maia (OR 1.22 (95% CI 0.78–1.92)). The pooled effect of the four studies resulted in an OR 1.18 (95% CI 1.03–1.36, P=0.02).ConclusionsOur results indicate that in a case–control study, the homozygosity for D2 Thr92Ala polymorphism is associated with increased risk for DM2. These results were confirmed by a meta-analysis including 11 033 individuals, and support a role for intracellular T3 concentration in skeletal muscle on DM2 pathogenesis.


Endocrine ◽  
2016 ◽  
Vol 57 (2) ◽  
pp. 352-355
Author(s):  
Nadia Pallotta ◽  
Tiziana Filardi ◽  
Anna Carnovale ◽  
Luciano Nieddu ◽  
Paola Mariani ◽  
...  

2012 ◽  
Vol 15 (8) ◽  
pp. 1437-1441 ◽  
Author(s):  
Lina Radzevičienė ◽  
Rytas Ostrauskas

AbstractObjectiveType 2 diabetes mellitus appears to involve an interaction between susceptible genetic backgrounds and environmental factors including highly calorific diets. As it is important to identify modifiable risk factors that may help reduce the risk of type 2 diabetes mellitus, the aim of the present study was to determine the association between egg consumption and the risk of type 2 diabetes mellitus.DesignA specifically designed questionnaire was used to collect information on possible risk factors of type 2 diabetes mellitus. The odds ratios and 95 % confidence intervals for type 2 diabetes mellitus were calculated by conditional logistic regression.SettingA case–control study in a Lithuanian out-patient clinic was performed in 2001.SubjectsA total of 234 cases with a newly confirmed diagnosis of type 2 diabetes mellitus and 468 controls free of the disease.ResultsVariables such as BMI, family history of diabetes, cigarette smoking, education, morning exercise and plasma TAG level were retained in multivariate logistic regression models as confounders because their inclusion changed the value of the odds ratio by more than 10 % in any exposure category. After adjustment for possible confounders more than twofold increased risk of type 2 diabetes mellitus was determined for individuals consuming 3–4·9 eggs/week (OR = 2·60; 95 % CI 1·34, 5·08) and threefold increased risk of the disease was determined for individuals consuming ≥5 eggs/week (OR = 3·02; 95 % CI 1·14, 7·98) compared with those eating <1 egg/week.ConclusionsOur data support a possible relationship of egg consumption and increased risk of type 2 diabetes mellitus.


Diabetologia ◽  
2015 ◽  
Vol 58 (11) ◽  
pp. 2525-2532 ◽  
Author(s):  
Rebecka Hjort ◽  
Lars Alfredsson ◽  
Per-Ola Carlsson ◽  
Leif Groop ◽  
Mats Martinell ◽  
...  

2017 ◽  
Vol 33 (8) ◽  
pp. e2922 ◽  
Author(s):  
Douglas C. Chang ◽  
Paolo Piaggi ◽  
Robert L. Hanson ◽  
William C. Knowler ◽  
Clifton Bogardus ◽  
...  

2004 ◽  
Vol 89 (9) ◽  
pp. 4371-4376 ◽  
Author(s):  
Aneliya Parvanova ◽  
Ilian Iliev ◽  
Marco Filipponi ◽  
Borislav D. Dimitrov ◽  
Monica Vedovato ◽  
...  

Author(s):  
Meesha Iqbal ◽  
Paramjit Gill ◽  
Iqbal Azam ◽  
Romaina Iqbal

Women who develop diabetes during pregnancy (Gestational diabetes mellitus-GDM) increase their risk of developing type 2 diabetes mellitus (T2DM) post-partum by 70%. The average time to develop T2DM varies and is not widely studied. T2DM is associated with increased risk of developing dyslipidemia leading to cardiovascular diseases. We intended to study the association of dyslipidemia and T2DM as early as 6 weeks post-partum. A matched case control study was designed, and conditional logistic regression analysis applied to get adjusted matched odds with 95% confidence intervals. Our study revealed increased serum LDL levels in the cases compared to the controls (p=0.03). However, no association was seen with other lipid parameters. 


Sign in / Sign up

Export Citation Format

Share Document